Promomed Group: Geographic Expansion
Promomed Group (Russian pharmaceutical company) is expanding into Vietnam's pharmaceutical market with strategic partnerships. Founder Petr Bely met with Vietnam's Minister of Health to discuss long-term cooperation, technology transfer, and manufacturing operations targeting innovative drugs, biosimilars, and monoclonal antibodies
Source: discovered:vir.com.vn
The leadership read
Market entry of this kind typically deepens demand for biotech & pharma leadership bench strength in the region over the following 12–18 months.
Market context: This lands while the Talent Market Index reads 98.6 (Neutral) — down 1.4 versus the prior month — and Asia signal share is rising (+2.4pts).
Promomed Group: 1 signal in the last 90 days — in line with the Biotech & Pharma median of 1 across 19 tracked companies; 0.1% of MitchelLake's Asia signal flow.
Market entry — the MitchelLake playbook
When a company expands into a new market, the first leadership hires decide whether it lands. A selection of market entries we've run:
Market entry · Oceania
Square
Executive Search Fintech
Market entry
Dropbox
Executive Search for SaaS
Market entry · Asia
Deliveroo
Executive Search in ASEAN
Market entry · Oceania
SurveyMonkey
Managing Director APAC (first hire in region) / Country Manager
Market entry · Asia
LivePerson
Director ASEAN (first hire in region); also Head of Presales APAC
Market entry · Oceania
Etsy
Managing Director, Australia + Asia (MD APAC)
MitchelLake in this thematic
Our work · 2019
Director Product Engineering
SEEK Limited
Asia · Technology · digital-transformation · cross-border
Our work · 2019
Head of Talent
Invitae
Americas · Life Sciences · brand awareness challenge · tech life sciences hybrid
Our work · 2018
Head of Talent
Invitae
Americas · Biotech · talent acquisition · team leadership
More signals across Biotech & Pharma
Geographic Expansion · Asia
Thermo Fisher Scientific →Thermo Fisher Scientific's Manila Shared Services Centre is scaling rapidly from 100 to ~700 employees by 2026, positioning itself as a high-impact regional hub for Asia-Pacific operations with focus on digital transformation and strategic value creation beyond cost efficiency.
Capital Raising · Asia
Legend Biotech →First Beijing Investment Ltd acquired $43.78 million stake (2.3M shares) in Legend Biotech, a cancer cell therapy developer
Partnership · Asia
Bristol Myers Squibb →Bristol Myers Squibb partners with China's Hengrui Pharma on a $15.2 billion deal to advance more than a dozen early-stage drugs
Ma Activity · Asia
Gilead Sciences →Gilead Sciences agreed to acquire Ouro Medicines for up to $2.18 billion, gaining rights to antibody drug licensed from China's Keymed Biosciences
Geographic Expansion · Americas
Novartis AG →Novartis is expanding its U.S. manufacturing footprint by establishing a new site in Texas
Geographic Expansion · EMEA
Cambrex →Cambrex completed initial engineering studies for new large-scale API manufacturing plant expansion in US and Europe
Intelligence powered by Autonodal ↗